These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20112328)

  • 21. Fatty acid amide hydrolase: from characterization to therapeutics.
    Labar G; Michaux C
    Chem Biodivers; 2007 Aug; 4(8):1882-902. PubMed ID: 17712824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain.
    Jhaveri MD; Richardson D; Robinson I; Garle MJ; Patel A; Sun Y; Sagar DR; Bennett AJ; Alexander SP; Kendall DA; Barrett DA; Chapman V
    Neuropharmacology; 2008 Jul; 55(1):85-93. PubMed ID: 18534634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system.
    Fezza F; De Simone C; Amadio D; Maccarrone M
    Subcell Biochem; 2008; 49():101-32. PubMed ID: 18751909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the endocannabinoid-degrading enzyme fatty acid amide hydrolase by follicle-stimulating hormone.
    Grimaldi P; Rossi G; Catanzaro G; Maccarrone M
    Vitam Horm; 2009; 81():231-61. PubMed ID: 19647115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear localisation of the endocannabinoid metabolizing enzyme fatty acid amide hydrolase (FAAH) in invasive trophoblasts and an association with recurrent miscarriage.
    Chamley LW; Bhalla A; Stone PR; Liddell H; O'Carroll S; Kearn C; Glass M
    Placenta; 2008 Nov; 29(11):970-5. PubMed ID: 18805581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latest advances in the discovery of fatty acid amide hydrolase inhibitors.
    Bisogno T; Maccarrone M
    Expert Opin Drug Discov; 2013 May; 8(5):509-22. PubMed ID: 23488865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
    Petrosino S; Di Marzo V
    Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.
    Montanari S; Scalvini L; Bartolini M; Belluti F; Gobbi S; Andrisano V; Ligresti A; Di Marzo V; Rivara S; Mor M; Bisi A; Rampa A
    J Med Chem; 2016 Jul; 59(13):6387-406. PubMed ID: 27309570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring.
    Tarzia G; Duranti A; Gatti G; Piersanti G; Tontini A; Rivara S; Lodola A; Plazzi PV; Mor M; Kathuria S; Piomelli D
    ChemMedChem; 2006 Jan; 1(1):130-9. PubMed ID: 16892344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling.
    Lodola A; Mor M; Sirirak J; Mulholland AJ
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):363-7. PubMed ID: 19290863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.
    Colombano G; Albani C; Ottonello G; Ribeiro A; Scarpelli R; Tarozzo G; Daglian J; Jung KM; Piomelli D; Bandiera T
    ChemMedChem; 2015 Feb; 10(2):380-95. PubMed ID: 25338703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
    Seierstad M; Breitenbucher JG
    J Med Chem; 2008 Dec; 51(23):7327-43. PubMed ID: 18983142
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats.
    Adamczyk P; McCreary AC; Przegalinski E; Mierzejewski P; Bienkowski P; Filip M
    J Physiol Pharmacol; 2009 Sep; 60(3):119-25. PubMed ID: 19826190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison.
    Labar G; Vliet FV; Wouters J; Lambert DM
    Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
    Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
    J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Savinainen JR; Käsnänen H; Xhaard H; Nevalainen T; Laitinen JT; Poso A; Leppänen J; Saario SM
    ChemMedChem; 2009 Aug; 4(8):1253-9. PubMed ID: 19472270
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatty acid amide hydrolase controls mouse intestinal motility in vivo.
    Capasso R; Matias I; Lutz B; Borrelli F; Capasso F; Marsicano G; Mascolo N; Petrosino S; Monory K; Valenti M; Di Marzo V; Izzo AA
    Gastroenterology; 2005 Sep; 129(3):941-51. PubMed ID: 16143133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.
    Ortar G; De Petrocellis L; Moriello AS; Allarà M; Morera E; Nalli M; Di Marzo V
    Bioorg Med Chem Lett; 2013 Jan; 23(1):138-42. PubMed ID: 23206861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
    Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
    Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.